| 101211-1 |
Hantavirus sin nombre Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus sin nombre IgG Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101211-1 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
SNV IgG SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101212-9 |
Hantavirus hantaan Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus hantaan IgG Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101212-9 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
HTNV IgG SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101213-7 |
Hantavirus dobrava |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus dobrava [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101213-7 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
H dobrava SerPl Ql Line blot |
|
|
|
N |
|
H dobrava; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101214-5 |
Hantavirus Ab.IgM panel |
- |
Ser/Plas |
Pt |
- |
Line blot |
|
ACTIVE |
Hantavirus IgM panel - Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
101214-5 |
|
Line blot |
|
|
Order |
|
|
|
0 |
Hantavirus IgM panel SerPl Line blot |
|
|
|
N |
|
Hanta virus; Hantavirus IgM panel; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Orthohantavirus; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 101215-2 |
Hantavirus puumala Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101215-2 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
PUUV IgM SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; PUUV; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101216-0 |
Hantavirus sin nombre Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus sin nombre IgM Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101216-0 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
SNV IgM SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101217-8 |
Hantavirus hantaan Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus hantaan IgM Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101217-8 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
HTNV IgM SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101218-6 |
Hantavirus dobrava Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus dobrava IgM Ab [Presence] in Serum or Plasma by Line blot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101218-6 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
H dobrava IgM SerPl Ql Line blot |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H dobrava; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101219-4 |
Legionella sp DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Legionella sp DNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101219-4 |
|
Probe.amp.tar |
|
|
Observation |
|
|
|
0 |
Legionella DNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Legion; Legionela; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10122-0 |
ST wave displacement.mid.lead II |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead II |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10122-0 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-II |
|
|
|
Y |
|
2; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-II; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101220-2 |
SUMO-activating enzyme subunit 1 Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
SUMO-activating enzyme subunit 1 IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
101220-2 |
|
IA |
|
|
Both |
|
|
|
0 |
SAE1 IgG Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Dermatomyositis, Adult Type; EIA; ELFA; ELISA; Enz; Enzyme immunoassay; Enzymes; i; IAA; Immune globulin G; Immunoglobulin G; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; SAE1; Serology; Serum; Small-ubiquitin-like 40kD; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 101221-0 |
PM-SCL-100 extractable nuclear Ab |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
PM-SCL-100 extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
101221-0 |
|
IA |
|
|
Both |
|
|
|
0 |
ENA PM-SCL-100 Ab Ser IA-aCnc |
|
|
|
N |
|
ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; ENA; ENA PM-SCL-100; Enzyme immunoassay; Evening; IAA; MEIA; NA; Nuc; PM/SCL-100; PM1-alpha; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Serology; Serum; SR; SUDS |
2.75 |
2.74 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 101222-8 |
Meropenem+Vaborbactam |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Meropenem+Vaborbactam [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
101222-8 |
|
Agar diffusion |
|
|
Both |
|
|
|
0 |
Mero+Vab Islt KB |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Islt; Isol; KB; Kirby-bauer; Klebsiella pneumonia carbapenemase; KPC; Mero+Vab; Meronem; Merrem; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vabomere |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101223-6 |
Normorphine/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Normorphine/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/g creatinine |
|
|
|
|
|
|
DRUG/TOX |
|
101223-6 |
|
|
|
|
Observation |
|
|
|
0 |
Normorphine/Creat Ur |
|
|
|
N |
|
CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.75 |
2.74 |
|
|
|
|
|
|
|
ng/g{creat} |
|
|
|
0 |
| 101224-4 |
PKD1 gene & PKD2 gene deletion+duplication |
Find |
Bld/Tiss |
Pt |
Doc |
MLPA |
|
ACTIVE |
PKD1 and PKD2 gene deletion and duplication mutation analysis in Blood or Tissue by MLPA |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.DELDUP |
|
101224-4 |
|
MLPA |
|
|
Both |
|
|
|
0 |
PKD1 + PKD2 Del+Dup Bld/T MLPA |
|
|
|
N |
|
Amplification; APKD2; Blood; Del; Del+Dup; Deletions; Document; Dp; Finding; Findings; Molecular pathology; MOLPATH; MOLPATH.DELDUP; PBP; Pc-1; PC2; Pc-2; PKD1 + PKD2; PKD1+PKD2 gene; PKD4; Point in time; Polycystic kidney disease 1; polycystic kidney disease 1 (autosomal dominant); Polycystic kidney disease 2; polycystic kidney disease 2 (autosomal dominant); Polycystin-1 precursor; Random; Tissue; Tissue, unspecified; TRPP1; TRPP2; WB; Whole blood; Whole blood or Tissue |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101225-1 |
Hemosiderin |
PrThr |
Bld/Bone mar |
Pt |
Ord |
Prussian blue stain |
|
ACTIVE |
Hemosiderin [Presence] in Blood or Marrow by Prussian blue stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
101225-1 |
|
Prussian blue stain |
|
|
Both |
|
|
|
0 |
Hemosiderin Bld/Mar Ql Prus Bl St |
|
|
|
N |
|
Bld/Mar; Blood; BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Ordinal; Point in time; PR; Prus Bl St; Ql; Qual; Qualitative; Random; Screen; St; Stains; Stn; WB; Whole blood; Whole blood or Bone marrow |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101226-9 |
Recoverin Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Recoverin Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101226-9 |
|
IB |
|
|
Both |
|
|
|
0 |
Recoverin Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cancer-associated retinopathy; Immune blot; Immunobl; Immunoblot; Ordinal; Paraneoplastic Antibody; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; Small-cell lung cancer; SR; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101227-7 |
Recoverin Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Recoverin Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101227-7 |
|
IB |
|
|
Both |
|
|
|
0 |
Recoverin Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cancer-associated retinopathy; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Ordinal; Paraneoplastic Antibody; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Small-cell lung cancer; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101228-5 |
Purkinje cell cytoplasmic type Tr Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
PCA-Tr Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101228-5 |
|
IB |
|
|
Both |
|
|
|
0 |
PCA-Tr Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Hodgkin's lymphoma; Immune blot; Immunobl; Immunoblot; Limbic encephalopathy; Ordinal; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101229-3 |
Zinc finger protein of the cerebellum 4 Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Zinc finger protein of the cerebellum 4 Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101229-3 |
|
IB |
|
|
Both |
|
|
|
0 |
Zic4 Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Immune blot; Immunobl; Immunoblot; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; Prot; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; Small Cell Lung Cancer; SR; WB; WBLOT; West blot; West blt; Western blot; Zic4; Zn |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10123-8 |
ST wave displacement.mid.lead III |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
ST wave mid displacement in lead III |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10123-8 |
|
EKG |
|
|
Observation |
|
|
|
0 |
ST wave MD L-III |
|
|
|
Y |
|
3; Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Eklund; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; ST wave MD L-III; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 101230-1 |
Zinc finger protein of the cerebellum 4 Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101230-1 |
|
IB |
|
|
Both |
|
|
|
0 |
Zic4 Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Immune blot; Immunobl; Immunoblot; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; Prot; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Small Cell Lung Cancer; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot; Zic4; Zn |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101231-9 |
Neuronal nuclear Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101231-9 |
|
IB |
|
|
Both |
|
|
|
0 |
Hu Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; ANA; ANF; ANNA; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Blt; Cerebral spinal fluid; Cerebrospinal Fl; Hu; IMMUNE BLOT; Immunobl; Immunoblot; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101232-7 |
Glutamate decarboxylase 65 Ab |
PrThr |
CSF |
Pt |
Ord |
IB |
|
ACTIVE |
Glutamate decarboxylase 65 Ab [Presence] in Cerebral spinal fluid by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101232-7 |
|
IB |
|
|
Both |
|
|
|
0 |
GAD65 Ab CSF Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; Blt; c707; Cerebral spinal fluid; Cerebrospinal Fl; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; Immune blot; Immunobl; Immunoblot; Insulin-Dependent Diabetes Mellitus; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 101233-5 |
Glutamate decarboxylase 65 Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Glutamate decarboxylase 65 Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
101233-5 |
|
IB |
|
|
Both |
|
|
|
0 |
GAD65 Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Autoimmune myelopathy; Blt; c707; GAD; GAD65; GAD-65; GADA; Glu; Glutamic acid; Glutamic acid decarboxylase-65; Immune blot; Immunobl; Immunoblot; Insulin-Dependent Diabetes Mellitus; Ordinal; Paraneoplastic neurological syndrome; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serology; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.75 |
2.74 |
|
|
|
|
|
|
|
|
|
|
|
0 |
